NorthWest Biotherapeutics Inc (NWBO)

[abc1212]

abeta, based on the fact that we know how well Mesenchymal patients are doing, I was also interested to read the piece in Forbes that mentioned Epigenetic drugs

It said

Epigenetic drugs, which focus on flipping certain genes on or off (changing what the gene expresses) may hold promise

I may be barking up the wrong tree but what if there was another drug (as mentioned) that could switch off other gene expressions to end up with only Mesenchymal.

Then followed up with DCVax, well, I think that would speak for itself.

As I say, I may have this all wrong as not excactly sure what 'flipping genes on and off' accomplishes.

Any ideas?

Thanks